Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
5.52
-0.27 (-4.66%)
At close: Mar 28, 2025, 4:00 PM
5.64
+0.12 (2.17%)
After-hours: Mar 28, 2025, 6:02 PM EDT
CRBP Stock Forecast
CRBP's stock price has decreased by -84.48% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for CRBP stock have an average target of 60.89, with a low estimate of 35 and a high estimate of 88. The average target predicts an increase of 1,003.08% from the current stock price of 5.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBP stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 4 | 4 | 5 | 5 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 → $50 | Strong Buy | Reiterates | $75 → $50 | +805.80% | Mar 12, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $70 → $53 | Strong Buy | Maintains | $70 → $53 | +860.14% | Mar 11, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,258.70% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 → $75 | Strong Buy | Reiterates | $80 → $75 | +1,258.70% | Feb 10, 2025 |
Financial Forecast
Revenue This Year
1.46M
Revenue Next Year
5.39M
from 1.46M
Increased by 270.01%
EPS This Year
-5.29
from -3.68
EPS Next Year
-5.04
from -5.29
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5M | 26.3M | 26.3M | ||
| Avg | 1.5M | 5.4M | 4.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 1,701.6% | 386.9% | ||
| Avg | - | 270.0% | -20.1% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.02 | -3.30 | -2.93 | ||
| Avg | -5.29 | -5.04 | -6.16 | ||
| Low | -12.37 | -6.18 | -8.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.